Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.
| Last: | $1.67 |
|---|---|
| Change Percent: | -2.05% |
| Open: | $1.69 |
| Close: | $1.705 |
| High: | $1.695 |
| Low: | $1.6537 |
| Volume: | 367,680 |
| Last Trade Date Time: | 02/27/2026 12:45:54 pm |
| Market Cap: | $379,990,219 |
|---|---|
| Float: | 86,954,817 |
| Insiders Ownership: | 0.02% |
| Institutions: | 28 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.invivyd.com |
| Country: | US |
| City: | New Haven |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Invivyd Inc. (NASDAQ: IVVD).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
